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Nedd4-2 is a ubiquitin ligase previously demonstrated to regulate endocytosis and lyso-
somal degradation of the epithelial Na+ channel (ENaC) and other ion channels and trans-
porters. Recent studies using Nedd4-2 knockout mice specifically in kidney or lung epithelia
has revealed a critical role for this E3 ubiquitin ligase in regulating salt and fluid transport
in these tissues/organs and in maintaining homeostasis of body blood pressure. Interest-
ingly, the primary targets for Nedd4-2 may differ in these two organs: in the lung Nedd4-2
targets ENaC, and loss of Nedd4-2 leads to excessive ENaC function and to cystic fibro-
sis – like lung disease, whereas in the kidney, Nedd4-2 targets the Na+/Cl− cotransporter
(NCC) in addition to targeting ENaC. In accord, loss of Nedd4-2 in the distal nephron leads to
increased NCC abundance and function.The aldosterone-responsive kinase, Sgk1, appears
to be involved in the regulation of NCC by Nedd4-2 in the kidney, similar to its regulation of
ENaC. Collectively, these new findings underscore the physiological importance of Nedd4-2
in regulating epithelial salt and fluid transport and balance.
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INTRODUCTION
Neuronal precursor cell expressed developmentally downregu-
lated 4 (Nedd4) proteins are E3 ubiquitin ligases that belong to the
HECT family. They are composed of an N-terminal C2 domain
that directs subcellular localization or mediate intra-molecular
inhibitory interactions, multiple WW domains (usually three or
four) that recognize substrates by binding to PY motifs (PPxY or
LPxY), and a ubiquitin ligase HECT domain (Rotin and Kumar,
2009). In mammals, there are eight or nine Nedd4 family mem-
bers, including the closely related Nedd4 (Nedd4-1) and Nedd4-2
(NEDD4L; Yang and Kumar, 2010). While recent in vivo work
has suggested that Nedd4 is involved in regulating cellular growth,
differentiation and animal development (e.g., Cao et al., 2008;
Yang et al., 2008; Liu et al., 2009; Fouladkou et al., 2010; Kawabe
et al., 2010; Persaud et al., 2011), Nedd4-2 has been primarily
demonstrated to regulate ion transport by controlling cellular
trafficking/endocytosis and lysosomal degradation of ion chan-
nels and transporters. Of these, recent work on the regulation of
epithelial salt and fluid transport by Nedd4-2 in the kidney and
lung, using animal models, has received considerable attention,
and is therefore the focus of this review.
REGULATION OF ENaC BY NEDD4-2 IN KIDNEY AND LUNG
EPITHELIA
The amiloride-sensitive epithelial Na+ channel (ENaC) plays a
critical role in regulating salt and fluid absorption in epithelia of
the distal nephron, lung, distal colon, and other salt-absorbing tis-
sues. In accord, loss of function (LOF) mutations in ENaC cause
pseudohypoaldosteronism Type I (PHAI), and gain of function
(GOF) mutations cause pseudoaldosteronism (Liddle syndrome,
a hereditary hypertension), underscoring the importance of this
channel for Na+ and fluid absorption in the kidney (Lifton et al.,
2001). Similar diseases are also observed in knock in mice bearing
the same mutations found in PHAI or Liddle syndrome patients,
respectively; moreover, total ablation of ENaC in mice leads to
severe pulmonary edema (Hummler and Vallon, 2005). ENaC
function is up-regulated by the hormones aldosterone and vaso-
pressin (ADH) in the kidney, and by glucocorticoids in the lung
(Loffing and Korbmacher, 2009).
Epithelial Na+ channel is expressed in the distal convoluted
tubules (DCT), connecting tubules (CNT), and cortical collecting
ducts (CCD) of the distal nephron (Duc et al., 1994), and is com-
posed of three subunits, αβγ (Canessa et al., 1994); A PY motif is
present at the cytoplasmic C-terminal region of each ENaC subunit
(Snyder et al., 1995; Schild et al., 1996; Staub et al., 1996). Liddle
syndrome is caused by deletion or mutation of the PY motif of β
or γ ENaC (Shimkets et al., 1994; Hansson et al., 1995a,b; Lifton
et al., 2001). These PY motifs serve as binding sites for Nedd4 pro-
teins (Staub et al., 1996), especially Nedd4-2 (Abriel et al., 1999;
Harvey et al., 2001; Kamynina et al., 2001; Snyder et al., 2004b).
Like other Nedd4 family members, Nedd4-2 is comprised of a
C2-WW(x4)-HECT domain architecture. This E3 ligase binds, via
it WW domain, to the PY motifs of ENaC, leading to channel
ubiquitylation and endocytosis, thus suppressing ENaC function
(Figure 1A); this suppression is alleviated in Liddle syndrome (PY
motif) mutants, which cannot properly bind Nedd4-2 (Figure 1B)
and hence are retained at the plasma membrane for prolonged
times (Staub et al., 1996, 1997; Abriel et al., 1999; Kamynina et al.,
2001; Lu et al., 2007; Wiemuth et al., 2007; Zhou et al., 2007). Such
ENaC retention leads to excessive channel function and Na+ reab-
sorption, which significantly contributes to the development of
hypertension in these Liddle patients. The PY motifs of ENaC also
regulate its response to intracellular Na+ concentrations, because
the normal feedback inhibition by Na+ seen in wildtype ENaC is
inhibited in the PY motif mutants of this channel (Dinudom et al.,
1998; Kellenberger et al., 1998; Palmer et al., 1998).
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FIGURE 1 | Regulation of ENaC and NCC by Nedd4-2. (A) Under resting
conditions, Nedd4-2 inhibits ENaC and NCC, as does WNK4, ensuring no
excess Na+ (and fluid) reabsorption takes place, especially in the kidney. An
alternative model suggests that WNK4 activates NCC to a low degree by
activating the kinases SPAK and OSR1, which then phosphorylate (P) NCC.
WNK4 also inhibits the K+ channel ROMK, to restrain K+ excretion. (B) In
Liddle syndrome, PY motif mutations in ENaC prevent Nedd4-2 from
properly binding and suppressing ENaC, thus leading to increased ENaC
abundance/function and excessive Na+ (and fluid) reabsorption in the kidney,
causing hypertension. (C) Removal of Nedd4-2 in lung epithelia by gene
knockout in mice leads to cystic fibrosis – like lung disease due to excessive
abundance/function of ENaC. (D) Aldosterone (or Angiotensin II, AngII?)
stimulation of Sgk1 leads to Sgk1-mediated phosphorylation of Nedd4-2 on
two sites, thus preventing Nedd4-2 from suppressing NCC and ENaC. This
results in increased abundance/function of these Na+ absorbing proteins. In
addition, phosphorylation of WNK4 by Sgk1 interferes with the ability of
WNK4 to inhibit ENaC. Collectively, this leads to aldosterone-mediated
increased in Na+ and fluid reabsorption in the kidney, hence to elevated
blood pressure. (E) In PHAII, WNK4 mutants either divert NCC to the
recycling pathway instead of lysosomal degradation, and/or enhance
phosphorylation (and activation) of SPAK/OSR1 and hence of NCC. Both of
these effects, coupled with loss of inhibition of ENaC by WNK4, lead to
increased Na+ reabsorption (and paracellular Cl− permeability) in the kidney,
and hence to increased fluid absorption and hypertension. Mutant WNK4
also strongly suppresses ROMK, preventing K+ excretion and causing
hyperkalemia. (F) Knockout of Nedd4-2 in the distal nephron leads to
increased abundance and activation of NCC (and ENaC), causing
hypertension and possibly mimicking features of PHAII.
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Given the salt-induced hypertension, metabolic alkalosis and
hypokalemia observed in Liddle patients and in mice bearing the
Liddle syndrome mutations in βENaC (Pradervand et al., 1999),
one would expect that ablation of Nedd4-2 would result in a simi-
lar phenotype. Indeed,Yang and colleagues have recently generated
Nedd4-2 (total) knockout mice and showed that these mice exhibit
salt-induced hypertension (although milder than in the βENaC
mutant mice) and cardiac hypertrophy, which were inhibited by
amiloride (Shi et al., 2008; see below).
The suppressive effect of Nedd4-2 on ENaC led to a search for
mutations or polymorphism is NEDD4L (Nedd4-2) in hyperten-
sive patients. Although to date no mutations in NEDD4L have
been identified, polymorphisms in that gene that contribute to the
regulation of blood pressure by less efficiently suppressing ENaC,
have been described (Dunn et al., 2002; Fouladkou et al., 2004;
Araki et al., 2008; Luo et al., 2009). These Nedd4L variants cause
a rather mild effect on ENaC (e.g., Fouladkou et al., 2004) and it
is not known if they also affect the Na+/Cl− cotransporter (NCC;
see below).
As mentioned above, ENaC plays an important role in reg-
ulating salt/fluid absorption not only in the kidney, but also in
the lung. Knockout mice that ablate αENaC (the key subunit
in this channel) die at birth from an inability to clear their
lungs of fluid (Hummler et al., 1996). In contrast, mice bear-
ing a Liddle syndrome mutation demonstrate enhanced alveolar
fluid clearance following pulmonary edema (Randrianarison et al.,
2007).
An earlier study showed that (∼60%) knockdown of Nedd4-2
in rat lungs using RNA interference led to increased ENaC expres-
sion and to reduced extravascular lung fluid (Li et al., 2007).
Indeed, a very recent study using genetic ablation of Nedd4-2
specifically in lung epithelia in mice has demonstrated elevated
ENaC levels and function in lung epithelia harvested from these
mice, leading to lung dehydration, massive sterile inflammation
and mucus accumulation in the airways (Kimura et al., 2011);
these features resemble those seen in the lungs of cystic fibrosis
(CF) patients and also mimic the defects seen upon overexpression
of βENaC in lung epithelia (Mall et al., 2004; see below). Moreover,
they can be ameliorated by treatment of newborn knockout mice
with the ENaC inhibitor amiloride (Kimura et al., 2011); These
observations were also confirmed by a recent total knockout of
Nedd4-2 in mice (Boase et al., 2011) using a different knockout
approach than that described above by Shi et al. (2008), where
a lung phenotype was not described). In the Boase et al. (2011)
paper, systemic loss of Nedd4-2 led to neonatal death of many
of the newborns, likely due to elevated ENaC activity (although
no rescue studies were performed to confirm this), and surviving
mice, on a different genetic background, exhibited a lung phe-
notype very similar to that observed by Kimura et al. (2011),
described above. Collectively, these recent studies demonstrate
that Nedd4-2 normally suppresses ENaC function in the lung
(Figure 1C), a function that is important both at birth and at
later stages of life (Boase et al., 2011; Kimura et al., 2011), to
ensure normal pulmonary salt and fluid homeostasis. The inhibi-
tion of ENaC by Nedd4-2 in the lung resembles the suppression
of ENaC by CFTR in that tissue, although the mechanism for this
suppression is different.
CFTR has been shown to inhibit ENaC function in the air-
ways (Stutts et al., 1997; Boucher, 2007; although this notion has
been debated; e.g., Itani et al., 2011). In CF, in which CFTR func-
tion (Cl− secretion) is impaired, Na+ and fluid absorption are
increased. This results in airway dehydration, mucus accumula-
tion and repeated bacterial infections (Boucher, 2007; Donaldson
and Boucher, 2007). Mall, Boucher and co-workers have provided
strong support for this model, by demonstrating that overexpres-
sion of ENaC (βENaC) in mouse airways leads to a CF-like lung
phenotype, which was ameliorated by treatment of the mice with
amiloride early in neonatal life (Mall et al., 2004; Zhou et al.,
2008). An important question arising from these experiments was,
therefore, why do Liddle syndrome patients, exhibiting systemic
excessive ENaC activity, not develop CF-like lung disease? One
possible explanation (although likely not the only one) lies in
the difference between CFTR expression levels in the lower air-
ways of mice vs. humans. Unlike in humans, CFTR is only weakly
expressed in the distal airways of mice (Mall et al., 2010), thus it
may not be able adequately suppress the elevated levels of ENaC
obtained upon overexpression of its β subunit (Mall et al., 2004)
or upon knockout of Nedd4-2 (Kimura et al., 2011).
NEDD4-2 PARTICIPATES IN THE HORMONAL REGULATION OF
ENaC
Aldosterone and vasopressin are hormones well known to regu-
late Na+ balance and blood pressure, and both enhance ENaC
function. Serum and glucocorticoid-regulated kinase 1 (Sgk1, a
gene/protein related to Akt; Webster et al., 1993) is an aldosterone
and glucocorticoid responsive gene. Sgk1 enhances ENaC func-
tion primarily by increasing its levels at the plasma membrane in
response to aldosterone (Alvarez de la Rosa et al., 1999; Chen et al.,
1999; Naray-Fejes-Toth et al., 1999; Shigaev et al., 2000; Loffing
et al., 2001). This increase is achieved (at least in part) by Sgk1-
mediated phosphorylation of Nedd4-2 (Debonneville et al., 2001;
Snyder et al., 2002). Such phosphorylation leads to recruitment
of specific 14-3-3 isoforms (themselves induced by aldosterone;
Liang et al., 2006) to the phosphorylated Nedd4-2 (Bhalla et al.,
2005; Ichimura et al., 2005), resulting in blockade of the Nedd4-
2:ENaC interactions and loss of the ability of Nedd4-2 to suppress
ENaC (Debonneville et al., 2001; Snyder et al., 2002; Flores et al.,
2005; Figure 1D). Thus, this represents an important mechanism
(although not the only one – see Alvarez de la Rosa et al., 1999;
Shigaev et al., 2000; Auberson et al., 2003; Dahlmann et al., 2003;
Diakov and Korbmacher, 2004; Fejes-Toth et al., 2008) by which
aldosterone enhances ENaC function.
Much like Sgk1, PKA can also phosphorylate Nedd4-2 and pre-
vent it from inhibiting ENaC (Snyder et al., 2004a). Since PKA
is activated by cAMP, which is generated by vasopressin release
and binding to its V2 receptor, it is likely that vasopressin, like
aldosterone, can increase ENaC cell surface abundance by inhibit-
ing Nedd4-2. In addition, the hormone insulin (Lee et al., 2007)
and the kinases IKKB (Edinger et al., 2009) and with no lysine 1
(WNK1; Xu et al., 2005) were also shown to up-regulate ENaC via
the Sgk1/Nedd4-2 pathway. In contrast,AMPK enhances the inter-
actions between Nedd4-2 and ENaC, leading to increased ENaC
endocytosis and channel downregulation under metabolic stress
(Carattino et al., 2005; Bhalla et al., 2006; Almaca et al., 2009).
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Moreover, the WNK4 kinase inhibits ENaC following its (WNK4)
phosphorylation by Sgk1 (Ring et al., 2007a,b; Figure 1D). Muta-
tions in WNK1 and WNK4 cause Pseudohypoaldosteronism Type
II (PHAII), as detailed below.
REGULATION OF NCC BY NEDD4-2
The thiazide-sensitive NCC, encoded by the SLC12A3 gene, is
expressed in the DCT of the nephron, and is known to play a
critical role in the regulation Na+ and fluid transport (reviewed in
Dimke, 2011). Ectopic expression of NCC in Xenopus oocytes and
other cells leads to thiazide-sensitive Na+ uptake. This, together
with the finding of expression of NCC in the DCT, suggests
that this transporter plays an important role in regulation of
salt and fluid balance. Indeed, Gitleman syndrome, a salt-losing
disease exhibiting hypokalemic metabolic alkalosis, hypomagne-
semia, and hypocalciuria, is caused by LOF mutations in NCC
(SLC12A3; Simon et al., 1996).
NCC has been shown to be tightly regulated by several kinases,
primarily by WNK 1 and 4, which regulate NCC trafficking and
lysosomal sorting, phosphorylation, and function (Dimke, 2011;
Figure 1A). Phosphorylation of several Ser/Thr residues on NCC
appears to positively regulate its activity (Pacheco-Alvarez et al.,
2006). Interestingly, a GOF mutation in WNK1, GOF or mis-
sense mutations in WNK4, all leading to elevated NCC function,
cause PHAII (Figure 1E; Wilson et al., 2001; Lalioti et al., 2006;
Kahle et al., 2008). PHAII is characterized by increased renal
Na+ reabsorption (leading to hypertension), defective K+ secre-
tion (hyperkalemia) and metabolic acidosis, exactly opposite to
Gitleman syndrome. Treatment of PHAII patients with thiazide
corrects these abnormalities, implicating excessive function of
NCC as the culprit in this disease. Exactly how mutated WNK1
and WNK4 increase NCC function has been the subject of some
debate. WNK4 was proposed to target NCC for lysosomal degra-
dation (Subramanya et al., 2009), and accordingly, LOF mutations
in WNK4 were shown to increase cell surface abundance of NCC
(Wilson et al.,2003;Yang et al.,2003). Alternatively, it was proposed
that WNK4 activates its substrates, the Ste20 kinases SPAK and
OSR1, which in turn phosphorylate and activate NCC (Figure 1A).
In GOF mutations in WNK4 that cause PHAII, this phosphoryla-
tion cascade is enhanced, leading to increased activation of NCC
(Yang et al., 2007; Chiga et al., 2011; Figure 1E). Although this
needs to be investigated further, it is possible that different muta-
tions in WNK4 give rise to LOF or GOF, in either case leading to
enhanced NCC function (by different routes; Figure 1E). Regard-
ing WNK1, it was proposed to inhibit WNK4, hence a GOF WNK1
mutant found in PHAII was suggested to enhance suppression of
WNK4, thus resulting in increased NCC function (Yang et al.,
2003). Mutant WNK1 was also proposed to enhance phosphory-
lation of SPAK/OSR1, hence stimulating NCC phosphorylation
and activation.
Using inducible conditional knockout of Nedd4-2 specifically
in renal tubules of mice, it was recently shown that deletion of
Nedd4-2 in this region of the distal nephron leads, in addition to
an increase in abundance of ENaC, to a dramatic elevation in NCC
protein expression and a reduction in aldosterone levels (Arroyo
et al., 2011; Figure 1F). Moreover, Nedd4-2 was demonstrated (in
Hek293 cells) to bind NCC, likely indirectly, and to promote NCC
ubiquitylation and downregulation of its cell surface pool (Arroyo
et al., 2011). This suggests that in the DCT, NCC is a major sub-
strate for Nedd4-2. It is not clear why this elevated NCC expression
was not detected in the Nedd4-2 total knockout mice generated by
Shi et al. (2008) using the same Nedd4-2 floxed mice for genetic
crosses; possible explanations include differences in genetic back-
ground, differences in acute knockout (Arroyo et al., 2011) vs.
chronic knockout (Shi et al., 2008), which could potentially allow
compensation by other genes during development, or non-renal
effects of total knockout of Nedd4-2 in the Shi et al. (2008) mice.
The Nedd4-2-mediated suppression of NCC in the kidney
involves Sgk1, which phosphorylates Nedd4-2 in response to
aldosterone stimulation at two sites, thus inhibiting the ability of
this E3 ligase to suppress NCC (Arroyo et al., 2011; Figure 1D). In
this regard, the Nedd4-2 mediated downregulation of NCC is sim-
ilar to its downregulation of ENaC, although unlike ENaC, NCC
does not contains classic PY motifs and likely does not interact
directly with Nedd4-2.
Thus, it is clear that Nedd4-2 is able to regulate more than
one salt-absorbing targets/pathways, and this regulation is tissue-
specific. For example, in the distal nephron, Nedd4-2 regulates
the stability of NCC and that of ENaC (Arroyo et al., 2011),
whereas in the lung ENaC is a major target for Nedd4-2 regu-
lation (Boase et al., 2011; Kimura et al., 2011), as described above.
Putative Nedd4-2 targets in other salt-absorbing epithelia is/are
still unknown.
It is also apparent from the above studies that Sgk1 plays a
very important role in regulating ENaC and NCC, via phospho-
rylation and hence inhibition of Nedd4-2 function. To confirm
its importance in vivo, several groups have generated Sgk1 knock-
out mice. Both Wulff et al. (2002) and Fejes-Toth et al. (2008)
generated total Sgk1 knockout mice, which exhibited salt-wasting
phenotype under low salt diet, as well as reduced ENaC expression.
The latter study also showed weaker expression of NCC (Fejes-
Toth et al., 2008). In support, kidney-specific knockout of Sgk1
resulted in a salt-losing phenotype, especially under low salt diet,
with hyperkaliuria and low blood pressure,and with reduced phos-
phorylation of Nedd4-2, leading to decreased expression of NCC
(and to a lesser extent reduced expression of ENaC; Faresse et al.,
2012). These findings underscore the importance of Sgk1 in reg-
ulating the Nedd4-2:NCC interactions, as well as the previously
described Nedd4-2:ENaC interactions, in the kidney.
SUMMARY/PERSPECTIVE
Recent knockout studies of Nedd4-2 in both the distal nephron
and in lung epithelia have helped cement our understanding of
the suppressive role of Nedd4-2 on ENaC, which was extensively
studied earlier using cultured cells and Xenopus oocytes. Moreover,
these in vivo knockout studies have uncovered a new unsuspected
role for Nedd4-2 in suppressing NCC in the kidney. Collectively,
these animal model studies have important implications to our
understanding of human diseases, since total loss of Nedd4-2 leads
to salt-induced hypertension, and its specific loss in lung epithe-
lia results in CF-like lung disease. Additionally, given the large
increase in NCC abundance in the kidney upon knockout Nedd4-
2 specifically in the distal nephron, it may be speculated that such
an increase could result in PHAII-like disease (Figure 1F). This
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needs to be confirmed experimentally. Identification of LOF muta-
tions in NEDD4L in humans that are associated with PHAII (if
ever identified) would further strengthen the current studies with
knockout mouse models. Regardless, it is clear that Nedd4-2 plays
a critical role in regulating salt and fluid balance in the body, by
affecting Na+ and fluid absorption in organs such as the kidney
and the lung. The very recent identification of mutations in the
ubiquitin ligase KLHL3/CUL3 that cause PHAII (Boyden et al.,
2012; Louis-Dit-Picard et al., 2012), which lead to hypertension
by affecting NCC abundance/function, further underscores the
importance of E3 ubiquitin ligases in the regulation of body salt
and fluid homeostasis.
REFERENCES
Abriel, H., Loffing, J., Rebhun, J. F.,
Pratt, J. H., Schild, L., Horisberger,
J. D., Rotin, D., and Staub, O. (1999).
Defective regulation of the epithe-
lial Na+ channel by Nedd4 in Lid-
dle’s syndrome. J. Clin. Invest. 103,
667–673.
Almaca, J., Kongsuphol, P., Hieke,
B., Ousingsawat, J., Viollet, B.,
Schreiber, R., Amaral, M. D.,
and Kunzelmann, K. (2009).
AMPK controls epithelial Na(+)
channels through Nedd4-2 and
causes an epithelial phenotype
when mutated. Pflugers Arch. 458,
713–721.
Alvarez de la Rosa, D., Zhang, P.,
Naray-Fejes-Toth, A., Fejes-Toth, G.,
and Canessa, C. M. (1999). The
serum and glucocorticoid kinase sgk
increases the abundance of epithe-
lial sodium channels in the plasma
membrane of Xenopus oocytes. J.
Biol. Chem. 274, 37834–37839.
Araki, N., Umemura, M., Miyagi, Y.,
Yabana, M., Miki, Y., Tamura, K.,
Uchino, K., Aoki, R., Goshima,
Y., Umemura, S., and Ishigami, T.
(2008). Expression, transcription,
and possible antagonistic interac-
tion of the human Nedd4L gene
variant: implications for essen-
tial hypertension. Hypertension 51,
773–777.
Arroyo, J. P., Lagnaz, D., Ronzaud,
C., Vazquez, N., Ko, B. S., Mod-
des, L., Ruffieux-Daidie, D., Hausel,
P., Koesters, R., Yang, B., Stokes, J.
B., Hoover, R. S., Gamba, G., and
Staub, O. (2011). Nedd4-2 mod-
ulates renal Na+-Cl−cotransporter
via the aldosterone-SGK1-Nedd4-2
pathway. J. Am. Soc. Nephrol. 22,
1707–1719.
Auberson, M., Hoffmann-Pochon, N.,
Vandewalle, A., Kellenberger, S., and
Schild, L. (2003). Epithelial Na+
channel mutants causing Liddle’s
syndrome retain ability to respond
to aldosterone and vasopressin. Am.
J. Physiol. Renal Physiol. 285, F459–
F471.
Bhalla, V., Daidie, D., Li, H., Pao, A.
C., LaGrange, L. P., Wang, J., Van-
dewalle, A., Stockand, J. D., Staub,
O., and Pearce, D. (2005). Serum-
and glucocorticoid-regulated kinase
1 regulates ubiquitin ligase neural
precursor cell-expressed, develop-
mentally down-regulated protein 4-
2 by inducing interaction with 14-3-
3. Mol. Endocrinol. 19, 3073–3084.
Bhalla, V., Oyster, N. M., Fitch, A. C.,
Wijngaarden, M. A., Neumann, D.,
Schlattner, U., Pearce, D., and Hal-
lows, K. R. (2006). AMP-activated
kinase inhibits the epithelial Na+
channel through functional regula-
tion of the ubiquitin ligase Nedd4-2.
J. Biol. Chem. 281, 26159–26169.
Boase, N. A., Rychkov, G. Y., Townley,
S. L., Dinudom, A., Candi, E., Voss,
A. K., Tsoutsman, T., Semsarian, C.,
Melino, G., Koentgen, F., Cook, D.
I., and Kumar, S. (2011). Respira-
tory distress and perinatal lethal-
ity in Nedd4-2-deficient mice. Nat.
Commun. 2, 287.
Boucher, R. C. (2007). Airway surface
dehydration in cystic fibrosis: patho-
genesis and therapy. Annu. Rev. Med.
58, 157–170.
Boyden, L. M., Choi, M., Choate, K.
A., Nelson-Williams, C. J., Farhi,
A., Toka, H. R., Tikhonova, I. R.,
Bjornson, R., Mane, S. M., Colussi,
G., Lebel, M., Gordon, R. D., Sem-
mekrot, B. A., Poujol, A., Valimaki,
M. J., De Ferrari, M. E., Sanjad, S.
A., Gutkin, M., Karet, F. E., Tucci,
J. R., Stockigt, J. R., Keppler-Noreuil
K, M., Porter, C. C., Anand, S. K.,
Whiteford, M. L., Davis, I. D., Dewar,
S. B., Bettinelli, A., Fadrowski, J. J.,
Belsha, C. W., Hunley, T. E., Nelson,
R. D., Trachtman, H., Cole, T. R.,
Pinsk, M., Bockenhauer, D., Shenoy,
M., Vaidyanathan, P., Foreman, J. W.,
Rasoulpour, M., Thameem, F., Al-
Shahrouri, H. Z., Radhakrishnan, J.,
Gharavi, A. G., Goilav, B., and Lifton,
R. P. (2012). Mutations in kelch-
like 3 and cullin 3 cause hyperten-
sion and electrolyte abnormalities.
Nature 482, 98–102.
Canessa, C. M., Schild, L., Buell, G.,
Thorens, B., Gautschi, I., Horis-
berger, J. D., and Rossier, B. C.
(1994). Amiloride-sensitive epithe-
lial Na+ channel is made of three
homologous subunits. Nature 367,
463–467.
Cao, X. R., Lill, N. L., Boase, N., Shi,
P. P., Croucher, D. R., Shan, H.,
Qu, J., Sweezer, E. M., Place, T.,
Kirby, P. A., Daly, R. J., Kumar, S.,
and Yang, B. (2008). Nedd4 controls
animal growth by regulating IGF-1
signaling. Sci. Signal. 1, ra5.
Carattino, M. D., Edinger, R. S., Grieser,
H. J., Wise, R., Neumann, D.,
Schlattner, U., Johnson, J. P., Kley-
man, T. R., and Hallows, K. R.
(2005). Epithelial sodium channel
inhibition by AMP-activated protein
kinase in oocytes and polarized renal
epithelial cells. J. Biol. Chem. 280,
17608–17616.
Chen, S. Y., Bhargava, A., Mastrober-
ardino, L., Meijer, O. C., Wang,
J., Buse, P., Firestone, G. L., Ver-
rey, F., and Pearce, D. (1999).
Epithelial sodium channel regulated
by aldosterone-induced protein sgk.
Proc. Natl. Acad. Sci. U.S.A. 96,
2514–2519.
Chiga, M., Rafiqi, F. H., Alessi, D. R.,
Sohara,E.,Ohta,A.,Rai,T.,Sasaki,S.,
and Uchida, S. (2011). Phenotypes
of pseudohypoaldosteronism type II
caused by the WNK4 D561A mis-
sense mutation are dependent on the
WNK-OSR1/SPAK kinase cascade. J.
Cell. Sci. 124, 1391–1395.
Dahlmann, A., Pradervand, S., Humm-
ler, E., Rossier, B. C., Frindt, G.,
and Palmer, L. G. (2003). Miner-
alocorticoid regulation of epithelial
Na+ channels is maintained in a
mouse model of Liddle’s syndrome.
Am. J. Physiol. Renal Physiol. 285,
F310–F318.
Debonneville, C., Flores, S. Y., Kamyn-
ina, E., Plant, P. J., Tauxe, C.,
Thomas, M. A., Munster, C., Chraibi,
A., Pratt, J. H., Horisberger, J. D.,
Pearce, D., Loffing, J., and Staub, O.
(2001). Phosphorylation of Nedd4-
2 by Sgk1 regulates epithelial Na(+)
channel cell surface expression.
EMBO J. 20, 7052–7059.
Diakov, A., and Korbmacher, C. (2004).
A novel pathway of epithelial
sodium channel activation involves
a serum- and glucocorticoid-
inducible kinase consensus motif
in the C terminus of the channel’s
alpha-subunit. J. Biol. Chem. 279,
38134–38142.
Dimke, H. (2011). Exploring the intri-
cate regulatory network controlling
the thiazide-sensitive NaCl cotrans-
porter (NCC). Pflugers Arch. 462,
767–777.
Dinudom,A., Harvey, K. F., Komwatana,
P., Young, J. A., Kumar, S., and Cook,
D. I. (1998). Nedd4 mediates con-
trol of an epithelial Na+ channel
in salivary duct cells by cytosolic
Na+. Proc. Natl. Acad. Sci. U.S.A. 95,
7169–7173.
Donaldson, S. H., and Boucher, R. C.
(2007). Sodium channels and cystic
fibrosis. Chest 132, 1631–1636.
Duc, C., Farman, N., Canessa, C.
M., Bonvalet, J. P., and Rossier,
B. C. (1994). Cell-specific expres-
sion of epithelial sodium channel
alpha, beta, and gamma subunits
in aldosterone-responsive epithe-
lia from the rat: localization by
in situ hybridization and immuno-
cytochemistry. J. Cell Biol. 127,
1907–1921.
Dunn, D. M., Ishigami, T., Pankow,
J., von Niederhausern, A., Alder, J.,
Hunt, S. C., Leppert, M. F., Lalouel,
J. M., and Weiss, R. B. (2002). Com-
mon variant of human NEDD4L
activates a cryptic splice site to form
a frameshifted transcript. J. Hum.
Genet. 47, 665–676.
Edinger, R. S., Lebowitz, J., Li, H.,
Alzamora, R., Wang, H., John-
son, J. P., and Hallows, K. R.
(2009). Functional regulation of the
epithelial Na+ channel by Ikap-
paB kinase-beta occurs via phos-
phorylation of the ubiquitin lig-
ase Nedd4-2. J. Biol. Chem. 284,
150–157.
Faresse, N., Lagnaz, D., Debonneville,
A., Ismailji, A., Maillard, M., Fejes-
Toth, G., Naray-Fejes-Toth, A., and
Staub, O. (2012). Inducible kidney
specific Sgk1 knock-out mice show a
salt losing phenotype. Am. J. Physiol.
Renal Physiol. 302, F977–F985.
Fejes-Toth, G., Frindt, G., Naray-Fejes-
Toth, A., and Palmer, L. G. (2008).
Epithelial Na+ channel activation
and processing in mice lacking
SGK1. Am. J. Physiol. Renal Physiol.
294, F1298–F1305.
Flores, S. Y., Loffing-Cueni, D., Kamyn-
ina, E., Daidie, D., Gerbex, C., Cha-
banel, S., Dudler, J., Loffing, J.,
and Staub, O. (2005). Aldosterone-
induced serum and glucocorticoid-
induced kinase 1 expression is
accompanied by Nedd4-2 phospho-
rylation and increased Na+ trans-
port in cortical collecting duct
cells. J. Am. Soc. Nephrol. 16,
2279–2287.
www.frontiersin.org June 2012 | Volume 3 | Article 212 | 5
Rotin and Staub Nedd4-2 and Na+ transport
Fouladkou, F., Alikhani-Koopaei, R.,
Vogt, B., Flores, S. Y., Malbert-Colas,
L., Lecomte, M. C., Loffing, J., Frey, F.
J., Frey, B. M., and Staub, O. (2004). A
naturally occurring human Nedd4-2
variant displays impaired ENaC reg-
ulation in Xenopus laevis oocytes.
Am. J. Physiol. Renal Physiol. 287,
F550–F561.
Fouladkou, F., Lu, C., Jiang, C., Zhou,
L., She, Y., Walls, J. R., Kawabe,
H., Brose, N., Henkelman, R. M.,
Huang, A., Bruneau, B. G., and
Rotin, D. (2010). The ubiquitin lig-
ase Nedd4-1 is required for heart
development and is a suppressor of
thrombospondin-1. J. Biol. Chem.
285, 6770–6780.
Hansson, J. H., Nelson-Williams, C.,
Suzuki, H., Schild, L., Shimkets,
R., Lu, Y., Canessa, C., Iwasaki, T.,
Rossier, B., and Lifton, R. P. (1995a).
Hypertension caused by a truncated
epithelial sodium channel gamma
subunit: genetic heterogeneity of
Liddle syndrome. Nat. Genet. 11,
76–82.
Hansson, J. H., Schild, L., Lu, Y., Wil-
son, T. A., Gautschi, I., Shimkets, R.,
Nelson-Williams, C., Rossier, B. C.,
and Lifton, R. P. (1995b). A de novo
missense mutation of the beta sub-
unit of the epithelial sodium chan-
nel causes hypertension and Liddle
syndrome, identifying a proline-rich
segment critical for regulation of
channel activity. Proc. Natl. Acad. Sci.
U.S.A. 92, 11495–11499.
Harvey, K. F., Dinudom, A., Cook,
D. I., and Kumar, S. (2001). The
Nedd4-like protein KIAA0439 is a
potential regulator of the epithelial
sodium channel. J. Biol. Chem. 276,
8597–8601.
Hummler, E., Barker, P., Gatzy, J., Beer-
mann, F., Verdumo, C., Schmidt,
A., Boucher, R., and Rossier, B. C.
(1996). Early death due to defec-
tive neonatal lung liquid clearance
in alpha-ENaC-deficient mice. Nat.
Genet. 12, 325–328.
Hummler, E., and Vallon, V. (2005).
Lessons from mouse mutants of
epithelial sodium channel and its
regulatory proteins. J. Am. Soc.
Nephrol. 16, 3160–3166.
Ichimura, T., Yamamura, H., Sasamoto,
K., Tominaga, Y., Taoka, M., Kaki-
uchi, K., Shinkawa, T., Takahashi, N.,
Shimada, S., and Isobe, T. (2005). 14-
3-3 proteins modulate the expres-
sion of epithelial Na+ channels by
phosphorylation-dependent inter-
action with Nedd4-2 ubiquitin lig-
ase. J. Biol. Chem. 280, 13187–13194.
Itani, O. A., Chen, J. H., Karp, P. H.,
Ernat, S., Keshavjee, S., Parkeh, K.,
Klesney-Tate, Z. J., and Welsh, M.
J. (2011). Human cystic fibrosis air-
way epithelia have reduced Cl- con-
ductance but not increased Na+
conductance. Proc. Natl. Acad. Sci.
U.S.A. 108, 10260–10265.
Kahle, K. T., Ring,A. M., and Lifton, R. P.
(2008). Molecular physiology of the
WNK kinases. Annu. Rev. Physiol. 70,
329–355.
Kamynina, E., Debonneville, C., Bens,
M., Vandewalle, A., and Staub, O.
(2001). A novel mouse Nedd4 pro-
tein suppresses the activity of the
epithelial Na+ channel. FASEB J. 15,
204–214.
Kawabe, H., Neeb, A., Dimova, K.,
Young, S. M. Jr., Takeda, M.,
Katsurabayashi, S., Mitkovski, M.,
Malakhova, O. A., Zhang, D. E.,
Umikawa, M., Kariya, K., Goebbels,
S., Nave, K. A., Rosenmund, C., Jahn,
O., Rhee, J., and Brose, N. (2010).
Regulation of Rap2A by the ubiqui-
tin ligase Nedd4-1 controls neurite
development. Neuron 65, 358–372.
Kellenberger, S., Gautschi, I., Rossier, B.
C., and Schild, L. (1998). Mutations
causing Liddle syndrome reduce
sodium-dependent downregulation
of the epithelial sodium channel in
the Xenopus oocyte expression sys-
tem. J. Clin. Invest. 101, 2741–2750.
Kimura, T., Kawabe, H., Jiang, C.,
Zhang, W., Xiang, Y. Y., Lu, C., Salter,
M. W.,Brose,N., Lu,W.Y., and Rotin,
D. (2011). Deletion of the ubiqui-
tin ligase Nedd4L in lung epithe-
lia causes cystic fibrosis-like disease.
Proc. Natl. Acad. Sci. U.S.A. 108,
3216–3221.
Lalioti,M. D.,Zhang, J.,Volkman,H. M.,
Kahle, K. T., Hoffmann, K. E., Toka,
H. R., Nelson-Williams, C., Ellison,
D. H., Flavell, R., Booth, C. J., Lu,
Y., Geller, D. S., and Lifton, R. P.
(2006). Wnk4 controls blood pres-
sure and potassium homeostasis via
regulation of mass and activity of the
distal convoluted tubule. Nat. Genet.
38, 1124–1132.
Lee, I. H., Dinudom, A., Sanchez-Perez,
A., Kumar, S., and Cook, D. I. (2007).
Akt mediates the effect of insulin
on epithelial sodium channels by
inhibiting Nedd4-2. J. Biol. Chem.
282, 29866–29873.
Li, T., Koshy, S., and Folkesson,
H. G. (2007). Involvement of
{alpha}ENaC and Nedd4-2 in the
conversion from lung fluid secretion
to fluid absorption at birth in the
rat as assayed by RNA interference
analysis. Am. J. Physiol. Lung Cell
Mol. Physiol. 293, L1069–L1078.
Liang, X., Peters, K. W., Butterworth, M.
B., and Frizzell, R. A. (2006). 14-3-3
isoforms are induced by aldosterone
and participate in its regulation of
epithelial sodium channels. J. Biol.
Chem. 281, 16323–16332.
Lifton, R. P., Gharavi, A. G., and Geller,
D. S. (2001). Molecular mechanisms
of human hypertension. Cell 104,
545–556.
Liu, Y., Oppenheim, R. W., Sugiura, Y.,
and Lin, W. (2009). Abnormal devel-
opment of the neuromuscular junc-
tion in Nedd4-deficient mice. Dev.
Biol. 330, 153–166.
Loffing, J., and Korbmacher, C. (2009).
Regulated sodium transport in the
renal connecting tubule (CNT)
via the epithelial sodium chan-
nel (ENaC). Pflugers Arch. 458,
111–135.
Loffing, J., Zecevic, M., Feraille, E.,
Kaissling, B., Asher, C., Rossier, B. C.,
Firestone, G. L., Pearce, D., and Ver-
rey, F. (2001). Aldosterone induces
rapid apical translocation of ENaC
in early portion of renal collect-
ing system: possible role of SGK.
Am. J. Physiol. Renal Physiol. 280,
F675–F682.
Louis-Dit-Picard, H., Barc, J., Trujil-
lano,D.,Miserey-Lenkei,S.,Bouatia-
Naji, N., Pylypenko, O., Beaurain,
G., Bonnefond, A., Sand, O., Simian,
C., Vidal-Petiot, E., Soukaseum, C.,
Mandet, C., Broux, F., Chabre, O.,
Delahousse, M., Esnault, V., Fiquet,
B., Houillier, P., Bagnis, C. I., Koenig,
J., Konrad, M., Landais, P., Mourani,
C., Niaudet, P., Probst, V., Thau-
vin, C., Unwin, R. J., Soroka, S. D.,
Ehret, G., Ossowski, S., Caulfield,
M., International Consortium For
Blood Pressure Icbp, Bruneval, P.,
Estivill, X., Froguel, P., Hadchouel,
J., Schott, J. J., and Jeunemaitre,
X. (2012). KLHL3 mutations cause
familial hyperkalemic hypertension
by impairing ion transport in the
distal nephron. Nat. Genet. 44,
456–460.
Lu, C., Pribanic, S., Debonneville, A.,
Jiang, C., and Rotin, D. (2007).
The PY motif of ENaC, mutated in
Liddle syndrome, regulates channel
internalization, sorting and mobi-
lization from subapical pool. Traffic
8, 1246–1264.
Luo, F., Wang, Y., Wang, X., Sun, K.,
Zhou, X., and Hui, R. (2009). A
functional variant of NEDD4L is
associated with hypertension, anti-
hypertensive response, and ortho-
static hypotension. Hypertension 54,
796–801.
Mall, M., Grubb, B. R., Harkema, J.
R., O’Neal, W. K., and Boucher,
R. C. (2004). Increased airway
epithelial Na+ absorption pro-
duces cystic fibrosis-like lung dis-
ease in mice. Nat. Med. 10,
487–493.
Mall, M. A., Button, B., Johannesson,
B., Zhou, Z., Livraghi, A., Cald-
well, R. A., Schubert, S. C., Schultz,
C., O’Neal, W. K., Pradervand, S.,
Hummler, E., Rossier, B. C., Grubb,
B. R., and Boucher, R. C. (2010).
Airway surface liquid volume reg-
ulation determines different airway
phenotypes in liddle compared with
betaENaC-overexpressing mice. J.
Biol. Chem. 285, 26945–26955.
Naray-Fejes-Toth, A., Canessa, C.,
Cleaveland, E. S., Aldrich, G., and
Fejes-Toth, G. (1999). sgk is an
aldosterone-induced kinase in the
renal collecting duct. Effects on
epithelial Na+ channels. J. Biol.
Chem. 274, 16973–16978.
Pacheco-Alvarez, D., Cristobal, P. S.,
Meade, P., Moreno, E., Vazquez, N.,
Munoz, E., Diaz, A., Juarez, M. E.,
Gimenez, I., and Gamba, G. (2006).
The Na+:Cl− cotransporter is acti-
vated and phosphorylated at the
amino-terminal domain upon intra-
cellular chloride depletion. J. Biol.
Chem. 281, 28755–28763.
Palmer, L. G., Sackin, H., and Frindt, G.
(1998). Regulation of Na+ channels
by luminal Na+ in rat cortical col-
lecting tubule. J. Physiol. 509(Pt 1),
151–162.
Persaud, A., Alberts, P., Hayes, M., Guet-
tler, S., Clarke, I., Sicheri, F., Dirks,
P., Ciruna, B., and Rotin, D. (2011).
Nedd4-1 binds and ubiquitylates
activated FGFR1 to control its endo-
cytosis and function. EMBO J. 30,
3259–3273.
Pradervand, S., Wang, Q., Burnier, M.,
Beermann, F., Horisberger, J. D.,
Hummler, E., and Rossier, B. C.
(1999). A mouse model for Liddle’s
syndrome. J. Am. Soc. Nephrol. 10,
2527–2533.
Randrianarison, N., Escoubet, B., Fer-
reira, C., Fontayne,A., Fowler-Jaeger,
N., Clerici, C., Hummler, E., Rossier,
B. C., and Planes, C. (2007). beta-
Liddle mutation of the epithelial
sodium channel increases alveo-
lar fluid clearance and reduces the
severity of hydrostatic pulmonary
oedema in mice. J. Physiol. 582,
777–788.
Ring, A. M., Cheng, S. X., Leng, Q.,
Kahle, K. T., Rinehart, J., Lalioti,
M. D., Volkman, H. M., Wilson, F.
H., Hebert, S. C., and Lifton, R. P.
(2007a). WNK4 regulates activity of
the epithelial Na+ channel in vitro
and in vivo. Proc. Natl. Acad. Sci.
U.S.A. 104, 4020–4024.
Ring, A. M., Leng, Q., Rinehart, J., Wil-
son, F. H., Kahle, K. T., Hebert, S. C.,
and Lifton, R. P. (2007b). An SGK1
site in WNK4 regulates Na+ chan-
nel and K+ channel activity and has
Frontiers in Physiology | Renal and Epithelial Physiology June 2012 | Volume 3 | Article 212 | 6
Rotin and Staub Nedd4-2 and Na+ transport
implications for aldosterone signal-
ing and K+ homeostasis. Proc. Natl.
Acad. Sci. U.S.A. 104, 4025–4029.
Rotin, D., and Kumar, S. (2009). Physio-
logical functions of the HECT family
of ubiquitin ligases. Nat. Rev. Mol.
Cell Biol. 10, 398–409.
Schild, L., Lu, Y., Gautschi, I., Schnee-
berger, E., Lifton, R. P., and Rossier,
B. C. (1996). Identification of a PY
motif in the epithelial Na chan-
nel subunits as a target sequence
for mutations causing channel acti-
vation found in Liddle syndrome.
EMBO J. 15, 2381–2387.
Shi, P. P., Cao, X. R., Sweezer, E. M., Kin-
ney, T. S., Williams, N. R., Husted, R.
F., Nair, R., Weiss, R. M., Williamson,
R. A., Sigmund, C. D., Snyder, P.
M., Staub, O., Stokes, J. B., and
Yang, B. (2008). Salt-sensitive hyper-
tension and cardiac hypertrophy in
mice deficient in the ubiquitin lig-
ase Nedd4-2. Am. J. Physiol. Renal
Physiol. 295, F462–F470.
Shigaev, A., Asher, C., Latter, H., Garty,
H., and Reuveny, E. (2000). Regu-
lation of sgk by aldosterone and its
effects on the epithelial Na(+) chan-
nel. Am. J. Physiol. Renal Physiol. 278,
F613–F619.
Shimkets, R. A., Warnock, D. G., Bositis,
C. M., Nelson-Williams, C., Hans-
son, J. H., Schambelan, M., Gill, J.
R. Jr., Ulick, S., Milora, R. V., Find-
ling, J. W., Canessa, C. M., Rossier, B.
C., and Lifton, R. P. (1994). Liddle’s
syndrome: heritable human hyper-
tension caused by mutations in the
beta subunit of the epithelial sodium
channel. Cell 79, 407–414.
Simon, D. B., Nelson-Williams, C.,
Bia, M. J., Ellison, D., Karet, F.
E., Molina, A. M., Vaara, I., Iwata,
F., Cushner, H. M., Koolen, M.,
Gainza, F. J., Gitleman, H. J., and
Lifton, R. P. (1996). Gitelman’s vari-
ant of Bartter’s syndrome, inherited
hypokalaemic alkalosis, is caused by
mutations in the thiazide-sensitive
Na-Cl cotransporter. Nat. Genet. 12,
24–30.
Snyder, P. M., Olson, D. R., Kabra,
R., Zhou, R., and Steines, J.
C. (2004a). cAMP and serum
and glucocorticoid-inducible kinase
(SGK) regulate the epithelial Na(+)
channel through convergent phos-
phorylation of Nedd4-2. J. Biol.
Chem. 279, 45753–45758.
Snyder, P. M., Steines, J. C., and Olson,
D. R. (2004b). Relative contribution
of Nedd4 and Nedd4-2 to ENaC reg-
ulation in epithelia determined by
RNA interference. J. Biol. Chem. 279,
5042–5046.
Snyder, P. M., Olson, D. R., and
Thomas, B. C. (2002). Serum
and glucocorticoid-regulated kinase
modulates Nedd4-2-mediated inhi-
bition of the epithelial Na+ channel.
J. Biol. Chem. 277, 5–8.
Snyder, P. M., Price, M. P., McDon-
ald, F. J., Adams, C. M., Volk, K.
A., Zeiher, B. G., Stokes, J. B., and
Welsh, M. J. (1995). Mechanism
by which Liddle’s syndrome muta-
tions increase activity of a human
epithelial Na+ channel. Cell 83,
969–978.
Staub, O., Dho, S., Henry, P., Correa, J.,
Ishikawa, T., McGlade, J., and Rotin,
D. (1996). WW domains of Nedd4
bind to the proline-rich PY motifs
in the epithelial Na+ channel deleted
in Liddle’s syndrome. EMBO J. 15,
2371–2380.
Staub, O., Gautschi, I., Ishikawa, T., Bre-
itschopf, K., Ciechanover, A., Schild,
L., and Rotin, D. (1997). Regula-
tion of stability and function of
the epithelial Na+ channel (ENaC)
by ubiquitination. EMBO J. 16,
6325–6336.
Stutts, M. J., Rossier, B. C., and Boucher,
R. C. (1997). Cystic fibrosis trans-
membrane conductance regulator
inverts protein kinase A-mediated
regulation of epithelial sodium
channel single channel kinetics. J.
Biol. Chem. 272, 14037–14040.
Subramanya, A. R., Liu, J., Ellison, D.
H., Wade, J. B., and Welling, P. A.
(2009). WNK4 diverts the thiazide-
sensitive NaCl cotransporter to
the lysosome and stimulates AP-
3 interaction. J. Biol. Chem. 284,
18471–18480.
Webster, M. K., Goya, L., Ge, Y., Maiyar,
A. C., and Firestone, G. L. (1993).
Characterization of sgk, a novel
member of the serine/threonine
protein kinase gene family which
is transcriptionally induced by
glucocorticoids and serum. Mol.
Cell. Biol. 13, 2031–2040.
Wiemuth, D., Ke, Y., Rohlfs, M., and
McDonald, F. J. (2007). Epithelial
sodium channel (ENaC) is multi-
ubiquitinated at the cell surface.
Biochem. J. 405, 147–155.
Wilson, F. H., Disse-Nicodeme, S.,
Choate, K. A., Ishikawa, K., Nelson-
Williams, C., Desitter, I., Gunel,
M., Milford, D. V., Lipkin, G. W.,
Achard, J. M., Feely, M. P., Dus-
sol, B., Berland, Y., Unwin, R. J.,
Mayan, H., Simon, D. B., Farfel, Z.,
Jeunemaitre, X., and Lifton, R. P.
(2001). Human hypertension caused
by mutations in WNK kinases. Sci-
ence 293, 1107–1112.
Wilson, F. H., Kahle, K. T., Sabath, E.,
Lalioti, M. D., Rapson, A. K., Hoover,
R. S., Hebert, S. C., Gamba, G.,
and Lifton, R. P. (2003). Molecular
pathogenesis of inherited hyperten-
sion with hyperkalemia: the Na-Cl
cotransporter is inhibited by wild-
type but not mutant WNK4. Proc.
Natl. Acad. Sci. U.S.A. 100, 680–684.
Wulff, P., Vallon, V., Huang, D. Y., Volkl,
H., Yu, F., Richter, K., Jansen, M.,
Schlunz, M., Klingel, K., Loffing, J.,
Kauselmann, G., Bosl, M. R., Lang,
F., and Kuhl, D. (2002). Impaired
renal Na(+) retention in the sgk1-
knockout mouse. J. Clin. Invest. 110,
1263–1268.
Xu, B. E., Stippec, S., Chu, P. Y.,
Lazrak, A., Li, X. J., Lee, B. H.,
English, J. M., Ortega, B., Huang,
C. L., and Cobb, M. H. (2005).
WNK1 activates SGK1 to regu-
late the epithelial sodium channel.
Proc. Natl. Acad. Sci. U.S.A. 102,
10315–10320.
Yang, B., Gay, D. L., MacLeod, M. K.,
Cao, X., Hala, T., Sweezer, E. M., Kap-
pler, J., Marrack, P., and Oliver, P. M.
(2008). Nedd4 augments the adap-
tive immune response by promot-
ing ubiquitin-mediated degradation
of Cbl-b in activated T cells. Nat.
Immunol. 9, 1356–1363.
Yang, B., and Kumar, S. (2010).
Nedd4 and Nedd4-2: closely
related ubiquitin-protein lig-
ases with distinct physiological
functions. Cell Death Differ. 17,
68–77.
Yang, C. L., Angell, J., Mitchell, R.,
and Ellison, D. H. (2003). WNK
kinases regulate thiazide-sensitive
Na-Cl cotransport. J. Clin. Invest.
111, 1039–1045.
Yang, S. S., Morimoto, T., Rai, T.,
Chiga, M., Sohara, E., Ohno, M.,
Uchida, K., Lin, S. H., Moriguchi,
T., Shibuya, H., Kondo, Y., Sasaki,
S., and Uchida, S. (2007). Mol-
ecular pathogenesis of pseudohy-
poaldosteronism type II: generation
and analysis of a Wnk4(D561A/+)
knockin mouse model. Cell Metab.
5, 331–344.
Zhou, R., Patel, S. V., and Snyder, P.
M. (2007). Nedd4-2 catalyzes ubiq-
uitination and degradation of cell
surface ENaC. J. Biol. Chem. 282,
20207–20212.
Zhou, Z., Treis, D., Schubert, S. C.,
Harm, M., Schatterny, J., Hirtz, S.,
Duerr, J., Boucher, R. C., and Mall,
M. A. (2008). Preventive but not
late amiloride therapy reduces mor-
bidity and mortality of lung disease
in betaENaC-overexpressing mice.
Am. J. Respir. Crit. Care Med. 178,
1245–1256.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 24 April 2012; paper pend-
ing published: 11 May 2012; accepted:
30 May 2012; published online: 21 June
2012.
Citation: Rotin D and Staub O (2012)
Nedd4-2 and the regulation of epithelial
sodium transport. Front. Physio. 3:212.
doi: 10.3389/fphys.2012.00212
This article was submitted to Frontiers
in Renal and Epithelial Physiology, a
specialty of Frontiers in Physiology.
Copyright © 2012 Rotin and Staub. This
is an open-access article distributed under
the terms of the Creative Commons Attri-
bution Non Commercial License, which
permits non-commercial use, distribu-
tion, and reproduction in other forums,
provided the original authors and source
are credited.
www.frontiersin.org June 2012 | Volume 3 | Article 212 | 7
